Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery
Author:
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference96 articles.
1. Regulation of chromatin by histone modifications;Bannister;Cell Res.,2011
2. Epigenetic protein families: a new frontier for drug discovery;Arrowsmith;Nat. Rev. Drug Discov.,2012
3. The language of covalent histone modifications;Strahl;Nature,2000
4. Lysine acetylation targets protein complexes and CoRegulates major cellular functions;Kumar;Science,2009
5. Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions;Hewings;J. Med. Chem.,2012
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An updated patent review of BRD4 degraders;Expert Opinion on Therapeutic Patents;2024-09-04
2. The P53–P21–RB1 pathway promotes BRD4 degradation in liver cancer through USP1;Journal of Biological Chemistry;2024-03
3. Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis;European Journal of Medicinal Chemistry;2024-02
4. Design, Synthesis, and Antitumor Activity of Novel Thioheterocyclic Nucleoside Derivatives Through its Preferential Interaction with C-Myc;2024
5. Targeting the epigenetic reader “BET” as a therapeutic strategy for cancer;Bioorganic Chemistry;2023-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3